Best Compounded Semaglutide Programs 2026: Ranked Provider Comparison

Last updated: May 2026. This is a buying guide focused on ranking the telehealth and pharmacy programs that still legitimately offer compounded semaglutide in 2026. For the educational background on what compounded semaglutide is and how it differs from FDA-approved brands, see our companion Compounded Semaglutide vs. Brand-Name Guide.

Key takeaways (May 2026)

Compounded semaglutide remains legally available in 2026 through 503A pharmacies for patients with documented clinical need, and through semaglutide+B12 combination products that qualify as distinct formulations.
After the FDA removed semaglutide from its drug shortage list in early 2025, the compounding market consolidated. Roughly six telehealth brands now dominate legitimate access.
Typical monthly pricing in 2026 runs $179 to $449 per month, versus roughly $1,349 cash for brand-name Wegovy, a per-mg cost difference of about 4x to 7x.
The strongest dose flexibility (custom 0.1 to 0.5 mg micro-titration) comes from Henry Meds, Mochi Health, and Remedy Meds.
B12 is bundled by default at Henry Meds, Mochi Health, Remedy Meds, and Eden; it is optional or unavailable elsewhere.
Always verify your pharmacy is a registered 503A facility through the state pharmacy board before paying. Pricing under $150 per month with no questionnaire is the biggest red flag in 2026.
If your insurance starts covering Wegovy or Zepbound, switching from compounded usually saves money even at zero copay tiers below $50.

The compounded semaglutide landscape in 2026

The 2026 compounded semaglutide market looks very different from 2023 and 2024. After the FDA declared the semaglutide shortage resolved in early 2025 and issued enforcement notices to several large compounding operations, the universe of legitimate providers shrank dramatically. The brands still operating fall into two legal lanes:

503A patient-specific compounding. A licensed prescriber documents a clinical reason a patient cannot use the FDA-approved version (allergy to an excipient, intolerance to fixed dose steps, cost barrier to adherence). A 503A pharmacy then prepares a patient-specific prescription.
Combination products. Semaglutide compounded with vitamin B12, glycine, or other additives that create a meaningfully different formulation from the reference brand. This pathway has been the workhorse of the post-shortage market.

Why do patients still actively seek compounded in 2026 even with Wegovy and Zepbound widely available?

Cost. Cash Wegovy is still about $1,349 per month at most pharmacies. Even with the Eli Lilly and Novo Nordisk direct-to-consumer programs, monthly out-of-pocket runs $349 to $499. Compounded remains the cheapest legitimate GLP-1 path.
Dose flexibility. Brand-name Wegovy comes in five fixed doses (0.25, 0.5, 1.0, 1.7, 2.4 mg). Compounded providers can titrate in increments as small as 0.1 mg, which matters for patients who develop nausea or GI side effects at the standard step-ups.
Brand intolerance. A minority of patients react to excipients or the injection pen format and tolerate a vialed compounded version better.

For the deeper “what is compounding, what is 503A vs. 503B, how is potency verified” explainer, read our Compounded vs. Brand-Name Semaglutide Guide. This page focuses on which providers are worth your money.

Quick comparison: top 6 compounded semaglutide providers in 2026

Provider	Starting price	Dose flexibility	B12 included	Format	States served
Henry Meds	$249/mo	Custom micro-titration	Yes (default)	Telehealth, vial	~45
Hers / Hims	$199/mo	Standard step-up	Optional	Telehealth, vial	~48
Remedy Meds	$179/mo	Flexible	Yes (default)	Telehealth, vial	~40
Mochi Health	$99/mo + membership	Highly flexible	Yes (default)	Telehealth + RD	~46
Ro Body (formerly Sequence)	$145–$229/mo	Standard	Optional	Telehealth, integrated	~48
Eden / Found / Others	$196–$299/mo	Varies	Eden: yes	Telehealth	30–45

#1 Henry Meds — best overall for dose flexibility and B12 combos

Henry Meds is the most consistently recommended compounded provider in 2026 because it pairs custom micro-titration with a B12 combination by default, uses well-known 503A pharmacy partners, and has been transparent about its post-shortage compliance pivot.

Pricing (May 2026): $249 per month, all-inclusive of medication, supplies, and unlimited clinician messaging. No insurance billing.
Dose options: Custom doses from 0.1 mg through 2.5 mg, titrated based on tolerance, not a fixed ladder.
B12: Included by default as a semaglutide+B12 combination product.
Pros: Strongest dose flexibility in the market, transparent pharmacy disclosure, no surprise fees, fast first-month shipping.
Cons: Slightly more expensive than Remedy Meds and Ro Body; not the cheapest option.

Check current Henry Meds pricing

#2 Hers / Hims — best brand trust and largest footprint

Hims (men) and Hers (women) run the largest weight-loss telehealth platform in the US and quietly remain one of the most reliable compounded sources in 2026. The women-focused Hers experience emphasizes hormone-sensitive titration and PCOS-friendly protocols, while Hims targets male metabolic health.

Pricing (May 2026): $199 per month for compounded semaglutide; bundled discounts available with annual plans.
Dose options: Standard step-up similar to Wegovy, with limited custom doses on request.
B12: Optional add-on, not default.
Pros: Publicly traded parent company, strong clinical infrastructure, 48-state coverage, generally fast shipping.
Cons: Less micro-titration flexibility; clinician interactions can feel scripted compared to boutique providers.

See Hims weight-loss program | See Hers weight-loss program

#3 Remedy Meds — best value for budget-conscious patients

Remedy Meds positions itself as a no-frills, value-first compounded provider. The $179 starting price and frequent first-month credits make it the cheapest entry point among legitimate operators in 2026.

Pricing (May 2026): $179 per month; new patient credits up to $120 commonly available.
Dose options: Flexible, including non-standard doses below 0.25 mg.
B12: Included by default.
Pros: Lowest legitimate price point with bundled B12, responsive clinician messaging.
Cons: Smaller staff means slightly slower message turnaround during peak demand; fewer ancillary services than Hims or Mochi.

Check Remedy Meds current pricing

#4 Mochi Health — best for obesity-medicine integrated care

Mochi Health stands out by combining compounded semaglutide with credentialed obesity-medicine physicians and registered dietitians. For patients with PCOS, metabolic syndrome, or post-bariatric weight regain, the clinical depth is materially better than commodity telehealth.

Pricing (May 2026): Membership starts around $99 per month plus medication; total monthly cost typically lands in the $199 to $299 range.
Dose options: Highly flexible, including ultra-low starter doses for high-sensitivity patients.
B12: Included by default in most plans.
Pros: Obesity-medicine specialty, RD support included, strong protocol for side-effect management.
Cons: Membership-plus-medication pricing can be confusing; total monthly cost may exceed simpler flat-rate providers.

Explore Mochi Health

#5 Sequence (now Ro Body) — best integrated platform under a major umbrella

Ro acquired Sequence in 2023 and folded it into Ro Body in 2024 to 2025. In 2026 it operates as a single GLP-1 weight-loss program that can prescribe compounded semaglutide where clinically appropriate, alongside brand-name Wegovy and Zepbound when insurance covers them. Useful if you want one provider that can pivot you between compounded and brand-name without switching platforms.

Pricing (May 2026): $145 per month base membership; compounded semaglutide bundles run $145 to $229 per month depending on dose.
Dose options: Standard step-up; less micro-titration than Henry or Mochi.
B12: Optional add-on.
Pros: Easy switch path to brand-name if insurance kicks in; backed by Ro’s large clinician network; insurance navigation support.
Cons: Less customization on dosing; some users report longer initial onboarding.

See Ro Body weight loss

#6 Eden, Found Health, and other smaller players

Beyond the top five, a second tier of providers continues to serve specific niches in 2026:

Eden: Compounded semaglutide+B12 at roughly $196 to $296 per month. Strong on B12 messaging and clinician access. Coverage in 30 to 35 states.
Found Health: Behavior-first platform that adds compounded GLP-1s as one tool among several. Best for patients who want coaching and habit support layered on the medication.
Medvi, MyStart, Sprout, Prime Health, HealthRX: Smaller telehealth operators with pricing between $179 and $299 per month. Verify the pharmacy partner is 503A-registered before purchasing.

These can be reasonable choices for specific situations (regional coverage, niche specialty) but lack the operational track record of the top five.

Also worth considering: Trim Rx — flat $199 injectable semaglutide at every dose

Trim Rx (founded June 2024, operated by MetaFit Pharma Solutions LLC) is too new to rank against the operational track record of the providers above, but its pricing structure stands out: injectable compounded semaglutide is $199 per month flat at every dose — no titration price jumps — with an oral semaglutide option at $179 per month and compounded tirzepatide at $349 per month flat, per TrimRx’s published pricing as of June 2026.

Pricing (June 2026): $179 per month oral semaglutide; $199 per month injectable semaglutide, flat at every dose; $349 per month compounded tirzepatide, flat at every dose. Multi-month plans can reduce the monthly cost — verify at checkout.
Dose options: Pricing does not change with dose, which removes the dose-escalation cost penalty most programs carry.
Pros: Flat pricing at every dose, both semaglutide and tirzepatide pathways, LegitScript-certified with licensed prescribers.
Cons: Young company with a Trustpilot rating of 3.2/5 across 3,316 reviews; complaint themes include slow support responses and cancellation friction.

Read the full Trim Rx review for the complete pricing table, complaint patterns, and billing terms before enrolling.

Dose flexibility comparison — why compounded wins on titration

The single biggest clinical reason patients still pay cash for compounded in 2026 is dose flexibility. Here is the contrast:

Brand-name Wegovy fixed doses: 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, 2.4 mg. You are required to escalate roughly monthly.
Brand-name Ozempic (off-label): 0.25 mg, 0.5 mg, 1.0 mg, 2.0 mg.
Compounded semaglutide: Custom doses including 0.1, 0.15, 0.2, 0.3, 0.4, 0.6, 0.8 mg and any intermediate value your prescriber sets.

Why this matters: roughly a quarter of GLP-1 starters discontinue within the first three months, and GI side effects are the leading cause. Patients who can pause at 0.35 mg instead of being forced from 0.25 to 0.5 mg often complete the titration that they would otherwise abandon. Henry Meds and Mochi Health are the strongest providers on this dimension; Hims and Ro Body are weakest because they more closely mirror the brand step-up.

Cost per milligram comparison — true normalized pricing

Headline monthly prices hide the real economics. Normalized to dollars per mg of semaglutide delivered at a 1.0 mg maintenance dose (roughly 4 mg per month):

Option	Monthly cost (cash)	Approx. cost per mg
Brand-name Wegovy (no insurance)	$1,349	~$1.95 per mg
Novo Nordisk NovoCare direct (2026)	$499	~$1.25 per mg
Remedy Meds compounded	$179	~$0.45 per mg
Hims/Hers compounded	$199	~$0.50 per mg
Mochi Health (medication portion)	$199–$299	~$0.50–$0.75 per mg
Henry Meds compounded	$249	~$0.62 per mg
Ro Body compounded	$145–$229	~$0.36–$0.57 per mg

Even the most expensive compounded option costs roughly one third of cash brand-name Wegovy on a per-mg basis. For patients without insurance coverage, that gap is the single most consequential reason the compounded market still exists in 2026.

B12 + semaglutide combinations — what to know

Many compounded providers include cyanocobalamin or methylcobalamin (vitamin B12) in their semaglutide formulation. The marketing language frames this as an “energy boost,” but the more important reasons are:

Regulatory. A semaglutide+B12 product is a meaningfully different formulation from FDA-approved Wegovy/Ozempic, which strengthens the legal basis for compounding under 503A rules even outside a declared shortage.
Clinical. Patients on aggressive calorie restriction sometimes develop subclinical B12 deficiency, particularly older adults or those on long-term metformin or PPIs.
Tolerability. Some compounding pharmacies report that B12 may modestly reduce reported fatigue during titration, though high-quality randomized evidence is limited.

Providers that include B12 by default in 2026: Henry Meds, Mochi Health, Remedy Meds, Eden. Optional add-on: Hims/Hers, Ro Body. If you take a multivitamin or B-complex already, additional B12 is generally harmless because it is water-soluble.

How to evaluate a compounded provider’s legitimacy

The post-2025 enforcement wave separated legitimate operators from gray-market sellers. Use this checklist before paying any provider:

Identify the pharmacy. The telehealth brand is not the pharmacy. Ask which 503A pharmacy fills your prescription. Decline to proceed if they refuse to disclose.
Verify the state pharmacy board license. Look up the pharmacy on the National Association of Boards of Pharmacy (NABP) verification tool and on the relevant state board website.
Confirm a licensed prescriber. You should receive an actual telehealth visit (sync or async) with a US-licensed physician, NP, or PA. A questionnaire-only flow with no clinician of record is a red flag.
Check the formulation. Reputable providers disclose strength, base (semaglutide acetate vs. base), and any combination ingredient (B12, glycine).
Watch for too-cheap pricing. Anything under $150 per month in 2026 with no medical questionnaire is almost certainly either unlicensed or sourcing from non-FDA-registered API. Walk away.
Verify DEA and FDA registration where applicable. 503A pharmacies do not need DEA registration for semaglutide (non-controlled), but they must be state-licensed and FDA-aware. 503B outsourcing facilities have additional FDA registration requirements.

For background on the regulatory framework, the FDA’s compounding pages and the agency’s 2024 to 2025 statements on GLP-1 compounding are the authoritative sources.

When to switch from compounded to brand-name

Compounded is not always the right long-term answer. Switch to FDA-approved Wegovy or Zepbound when:

Insurance starts covering brand-name. Many employer plans added GLP-1 coverage in the 2025 to 2026 plan years. If your effective brand copay falls below your compounded cash price, switch.
You hit therapeutic ceiling on compounded. If you are at the equivalent of 2.4 mg and not progressing, a switch to tirzepatide (Zepbound) may unlock additional response.
Severe side effects at custom doses. Persistent vomiting, gallbladder symptoms, or pancreatitis signals are reasons to step back from any GLP-1 and re-evaluate with an in-person clinician.
You want pen-injector convenience. Brand-name auto-injectors are easier than vial-and-syringe for many users, particularly those with dexterity issues.
You are pregnant or planning pregnancy. Discontinue all GLP-1s and consult OB-GYN; this is not a “switch” decision but a stop decision.

Frequently asked questions

Is compounded semaglutide legal in 2026?

Yes, when produced by a state-licensed 503A pharmacy for a patient with a documented clinical need, or as a meaningfully different combination product (most commonly with B12). The FDA removed semaglutide from the shortage list in early 2025, narrowing but not eliminating the legal lanes for compounding.

How is compounded semaglutide priced compared to Wegovy?

Compounded runs roughly $179 to $299 per month in 2026 versus about $1,349 cash for brand-name Wegovy and around $499 per month through Novo Nordisk’s NovoCare direct-to-consumer program. On a per-mg basis, compounded is typically 25 to 40 percent of the brand-name cash price.

What’s the cheapest legitimate compounded semaglutide program?

Remedy Meds at $179 per month with frequent new-patient credits is the lowest legitimate flat-rate price in May 2026. Ro Body can go lower at $145 base membership but adds medication cost on top.

Can I get compounded semaglutide with B12?

Yes. Henry Meds, Mochi Health, Remedy Meds, and Eden include B12 in the default formulation. Hims, Hers, and Ro Body offer B12 as an add-on. The B12 inclusion both supports the regulatory basis for compounding and may modestly help with reported fatigue.

How do I know my compounded pharmacy is legit?

Ask which 503A pharmacy fills your prescription, verify the license on the state pharmacy board’s online lookup, confirm you are seen by a US-licensed prescriber (not a questionnaire-only flow), and decline any provider charging under $150 per month with no medical intake.

Should I be worried about FDA crackdown on compounded?

Enforcement in 2025 targeted unlicensed sellers, non-503A operators, and providers sourcing from foreign unregistered API. Legitimate 503A telehealth pipelines have largely continued operating with adjusted formulations. The risk of your prescription being abruptly cut off is real but lower with the top-tier providers ranked above than with low-cost, low-disclosure operators.

Can I switch from compounded to Wegovy?

Yes. Your prescriber can map your current compounded dose to the nearest Wegovy step (typically a 1.0 mg compounded dose maps to 1.0 mg Wegovy, with 0.5 mg as a step-down option if needed). Most patients tolerate the transition without restarting titration if they have already been on a stable maintenance dose.

Which compounded program ships fastest?

In our 2026 testing, Hims, Henry Meds, and Ro Body had the most consistent first-shipment times (3 to 5 business days post-approval). Smaller providers and high-volume periods can stretch to 7 to 10 business days.

Bottom line

If you need compounded semaglutide in 2026, the top six providers above cover essentially every legitimate use case: Henry Meds for dose flexibility and B12, Hers/Hims for scale and trust, Remedy Meds for cheapest legitimate price, Mochi Health for clinical depth, Ro Body for an integrated path that can pivot to brand-name, and Eden/Found/others for niche needs. Verify the pharmacy, confirm a real prescriber, and revisit your choice if insurance coverage of brand-name GLP-1s improves on your plan.

Medical disclaimer: This article is for informational purposes only and is not medical advice. Compounded medications are not FDA-approved drug products. Any GLP-1 therapy, compounded or brand-name, should be initiated and supervised by a licensed clinician with knowledge of your full medical history. Stop and seek care for severe abdominal pain, persistent vomiting, signs of pancreatitis, gallbladder symptoms, or significant allergic reactions.

Affiliate disclosure: BestMedsHub may earn a commission when you sign up with a provider linked from this page. This does not affect our rankings; pricing, dose flexibility, B12 inclusion, and pharmacy legitimacy criteria are applied uniformly. Pricing is verified as of May 2026 and may change without notice.